Palmer Pamela P

Avg. Two Year Performance

(25%) Avg. Purchase Return
(12%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return3%24%(18%)(23%)(25%)
Purchase Success Rate2 of 41 of 40 of 41 of 41 of 4
Average Sale Return----------
Sale Success Rate----------

AcelRx Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

Chief Medical Officer:

Holdings: 59.15K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--